ArticleCancer medicine2026
Significance of Early Proton Beam Therapy Initiation in Achieving Complete Response in Pediatric Medulloblastoma: A Retrospective Study.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionProton beam therapy (PBT) has proven to be highly effective in treating pediatric medulloblastoma, offering both excellent therapeutic outcomes and reduced side effects. However, factors influencing tumor response following PBT remain poorly defined, including the optimal interval time between surgery and PBT initiation (ISP).
methodsThis retrospective study analyzed data from 52 patients with postoperative residual medulloblastoma treated with PBT, focusing on the correlation between tumor response and ISP, as well as other variables associated with achieving complete response (CR).
resultsThe median follow-up period was 12.5 months (5.3-20.3 months). Treatment response was assessable in all patients, with 26 (50.00%) patients in CR, 15 (28.85%) patients in partial response (PR), and 11 (21.15%) patients with stable disease (SD). Patients who initiated PBT within 31 days post-surgery had a markedly higher CR rate (74.07%), while those with longer ISPs were more likely to exhibit PR (32.00%) or SD (44.00%). An improved tumor response was significantly associated with a shorter ISP (30.15 ± 5.31 days, p < 0.001). Univariate logistic regression identified Chang staging M3 (Odds ratio [OR] = 0.103, p = 0.046), residual tumor size > 1.5 cm (OR = 0.278, p = 0.043), and longer ISP (OR = 0.906, p = 0.013)-particularly beyond 31 days (OR = 0.111, p = 0.001)-as factors associated with a lower likelihood of CR. Multivariate analysis further confirmed that ISP was the only independent factor correlated with CR (OR = 0.884, p = 0.009).
conclusionThis study highlights that the timely initiation of PBT following surgery, particularly within 31 days, is associated with improved CR in pediatric medulloblastoma. Our findings suggest that a shorter interval between surgery and PBT initiation may be an important factor influencing early treatment response, providing preliminary evidence to support earlier postoperative PBT delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.